Molecular Diagnostics
Innovative, Easy-to-Use Molecular Diagnostics Platform Advances Newborn Screening
Revvity Inc. has launched the EONIS Q system which has received CE-IVD certification, allowing laboratories in countries recognizing CE marking to implement molecular testing for SMA and SCID in newborns. More...28 Nov 2023
Next-Generation Benchtop Diagnostic Platform Delivers Rapid Multi-Gene Test Results
A benchtop diagnostic platform for fully integrated analysis of molecular biomarker signatures with a 4-hour automated workflow allows hospitals and pathology labs to perform multi-gene testing in-house. More...27 Nov 2023
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Automated Urinalysis Solution
UN-9000
New
Clinical Informatics Platform
CLARION™
In Other News
New Test Predicts If Brain Tumor Is Likely to Grow Back
Automated Serology Tests Diagnose Hepatitis E Virus Infection in Symptomatic and Asymptomatic Patients
Molecular Test Accurately Diagnoses Sepsis in Immunocompromised Patients
First-of-Its-Kind Test Determines Future Risk of Esophageal Cancer in Patients with Barrett's Esophagus
Non-Invasive Blood Test Detects Synovial Signatures in Rheumatoid Arthritis Patients
New Assay to Revolutionize Detection and Treatment of Acute Myeloid Leukemia
Genetic Testing Can Identify Patients with Inherited Risk of Cardiomyopathy
Wireless, Handheld, Non-Invasive Device Detects Alzheimer's and Parkinson's Biomarkers
New Rapid Test Detects Both HIV and TB in Blood Sample
Simple Blood Test Simultaneously Measures 21 Biomarkers for Cardiovascular Disease
Game-Changing Tumor Marker Test Detects Gastric Cancer with Nearly 90% Accuracy
World's Highest-Multiplex POC System with RNA Quantitating Ability Detects Bacterial Infection
New Multiple Sclerosis Test Delivers Rapid Results with Minimally Invasive Blood Draw
Groundbreaking Study Combines AI and Blood Tests to Identify Colorectal Cancer at Earliest Stages
Highly Sensitive Blood Test to Enable Earlier Detection of Common Deadly Cancers
Simple Blood Test Could Predict Alzheimer’s Risk 20 Years Before Symptoms Appear
Revolutionary Genomic Handheld Device Offers First-of-Kind Point-of-Decision, Lab in Cartridge PCR Test
Blood Tests Can Detect Inflammatory Bowel Diseases Years before Diagnosis
Metal-Enhanced Fluorescence-Based LFI Platform Detects Influenza A Virus in 20 Minutes
Blood Test Shows Worsening Disability in MS Patients 1 to 2 Years before Occurrence
Concurrent DNA and RNA Sequencing Improves Accuracy of Hereditary Cancer Testing
New Molecular Test Detects 14 High-Risk, Cancer-Causing HPV Genotypes
Virus Diagnosis Device Delivers Lab-Quality Results within Three Minutes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.